122TiPGeparDouze/NSABP B-59: A randomized double-blind phase III clinical trial of neoadjuvant chemotherapy with atezolizumab or placebo in patients with triple negative breast cancer (TNBC) followed by adjuvant atezolizumab or placebo. (13th May 2019)

Record Type:: Journal Article
Title:: 122TiPGeparDouze/NSABP B-59: A randomized double-blind phase III clinical trial of neoadjuvant chemotherapy with atezolizumab or placebo in patients with triple negative breast cancer (TNBC) followed by adjuvant atezolizumab or placebo. (13th May 2019)
Main Title:: 122TiPGeparDouze/NSABP B-59: A randomized double-blind phase III clinical trial of neoadjuvant chemotherapy with atezolizumab or placebo in patients with triple negative breast cancer (TNBC) followed by adjuvant atezolizumab or placebo
Authors:: Loibl, S
Jackisch, C
Rastogi, P
Seiler, S
Lucas, P C
Denkert, C
Costantino, J
Nekljudova, V
Wolmark, N
Geyer, C
Abstract:
Is Part Of:: Annals of oncology. Volume 30(2019)Supplement 3
Journal:: Annals of oncology
Issue:: Volume 30(2019)Supplement 3
Issue Display:: Volume 30, Issue 3 (2019)
Year:: 2019
Volume:: 30
Issue:: 3
Issue Sort Value:: 2019-0030-0003-0000
Page Start:
Page End:
Publication Date:: 2019-05-13
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdz097.014 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12034.xml